FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes

PMA: P950024 · Supplement: S117 · Decision Apr 15, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Basic Information

Device Name
Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes
Trade Name
CapSure Epicardial Pacing Lead (4968), CapSure Epicardial Pacing Lead (4965)
PMA Number
P950024
Supplement Number
S117
Device Class
FDA Class 3
Product Code
NVN
Generic Name
Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
April 15, 2026
Date Received
March 31, 2026
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

to reduce the bioburden monitoring frequency from bi-weekly to monthly

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NVN Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes